Sihuan Pharmaceutical Holdings Group Ltd.
Research Sihuan Pharmaceutical Holdings Group Ltd. (0460.HK) on Bullrun: market cap HKD 6.43B, P/E 17.6, dividend yield 1.6%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker0460.HK
- ExchangeHK
- CountryHong Kong
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyHKD
- Market capHKD 6.43B
- P/E17.6
- Dividend yield1.6%
- Financial periodFY2025
- RevenueCNY 2.62B
- Revenue growth37.7%
- Net incomeCNY 179.70M
- Free cash flow-CNY 218.06M
- Gross margin68.8%
Valuation Snapshot
latest market cap is HKD 6.43B; P/E is 17.6; dividend yield is 1.6%.
Peer valuation comparison
Latest P/E is 17.63x versus a Healthcare sector median of 21.74x (18.9% below).
Latest dividend yield is 1.55% versus a Healthcare sector median of 2.4% (35.4% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 2.62B | CNY 179.70M | -CNY 218.06M | 68.8% | 0.02 | CNY 3.56B | CNY 1.01B | CNY 5.85B |
| FY2024 | CNY 1.90B | -CNY 216.66M | CNY 89.77M | 65.3% | -0.02 | CNY 3.52B | CNY 974.01M | CNY 4.37B |
| FY2023 | CNY 1.86B | -CNY 54.02M | -CNY 95.93M | 69.6% | -0.01 | CNY 3.78B | CNY 1.26B | CNY 4.43B |
| FY2022 | CNY 2.18B | -CNY 1.91B | -CNY 547.44M | 68.2% | -0.21 | CNY 4.01B | CNY 1.29B | CNY 4.74B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 6.43B | 17.6 | 3.1% | 0.02 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.02 HKD, yield 1.6%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.01 CNY |
| FY2024 | 0.02 CNY |
| FY2023 | 0.04 CNY |
| FY2022 | 0.17 CNY |
| FY2021 | 0.02 CNY |
About Sihuan Pharmaceutical Holdings Group Ltd.
Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People's Republic of China, the United States, and internationally. It operates in three segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Sihuan Pharmaceutical Holdings Group Ltd.'s market cap?
Sihuan Pharmaceutical Holdings Group Ltd.'s market capitalization is HKD 6.43B.
What is Sihuan Pharmaceutical Holdings Group Ltd.'s P/E ratio?
Sihuan Pharmaceutical Holdings Group Ltd.'s price-to-earnings (P/E) ratio is 17.6.
Does Sihuan Pharmaceutical Holdings Group Ltd. pay a dividend?
Sihuan Pharmaceutical Holdings Group Ltd. has a dividend yield of 1.6%.
What does Sihuan Pharmaceutical Holdings Group Ltd. do?
Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People's Republic of China, the United States, and internationally. It operates in three segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. The company offers filling, shaping, supporting, supplementing, optoelectronic devices, body sculpturing, skin care, and other services, as well as non- or minimally invasive comprehensive medical aesthetics solutions.